Life Sciences

Article

Life Sciences

Life Sciences companies continue to respond to a changing global landscape, and strive to pursue innovative solutions to address today's challenges. The DTTL network understands the complexity of these challenges, and works with clients worldwide to drive progress and bring discoveries to life.

2022 global life sciences outlook

Digitalization at scale: Delivering on the promise of science

Life sciences companies face distinct challenges with their very visible role in drug pricing and access to medicines, and the pandemic only underscored this focus. Even during these unprecedented times over the last two years, many life sciences organizations have witnessed a scientific breakthrough. Shifts to more data-driven approaches across the value chain, greater collaborations, digital transformation, and the advancing CEO priorities are driving the change. A new bar has been set and companies are now willing to move beyond convention to solve the toughest challenges and stand to reap the biggest benefits.

Our 2022 Global Life Sciences Outlook focuses on the current state of the sector, explores seven trends shaping the industry and prepares stakeholders to take advantage of the many opportunities the pandemic has surfaced and accelerated. In the year ahead, forward-looking companies will adopt a think-digital-to-be-digital mindset and consider how these technologies can augment human capabilities and update execution of processes.

Read more

2022 Global Life Sciences Outlook

2021 global life sciences outlook

Possibility is now reality, sustaining forward momentum

Navigating the pandemic has been an all-encompassing, once-in-a-lifetime challenge. Globally, life sciences companies responded with leadership and are emerging stronger. How will life sciences companies continue to respond and what areas can they build resiliency going forward?

The life sciences sector has played a pivotal role amid the COVID-19 pandemic. To cope with the global crisis, traditional competitors partnered to accelerate research and develop the fastest novel vaccine in the history. Governments, health systems, payers, retail pharmacies, and nonprofits are now working collaboratively with the sector to provide widespread distribution and administration.

Read more

The future unmasked

The future unmasked

Predicting the future of healthcare and life sciences in 2025

What does the future hold for the life sciences and healthcare industry? Our latest predictions report looks ahead to the year 2025 to help you see what’s coming and to keep your organisation moving forward.

Each prediction is brought to life through snapshots of how patients, healthcare and life science companies and their staff might behave and operate in this new world. We explore the major trends and the key constraints to be overcome; and identify the evidence today to predict how near that future might be.

This year, inevitably, our predictions have been informed by the unparalleled impact of the COVID-19 pandemic on society in general and more specifically on how people perceive health risks. We have seen a new public appreciation of the contribution that healthcare and life sciences companies are making to each countries response and how these companies are paving the way for a new era of collaboration to identify and implement solutions. A key stand out has been the huge acceleration in the pace and scale of technology-enabled transformation across the whole health ecosystem.

Read more

The future unmasked

The future awakens

Life Sciences and Health Care Predictions 2022
The year is 2022. The quantified self is alive and well, digital technologies have transformed the culture of health care and new entrants have disrupted delivery models. This report from Deloitte UK's Centre for Health Solutions offers some predictions that, if they come true, will shake up the life sciences and health care industry in the next five years.
Read more
The future awakens
Did you find this useful?